Drishti Agarwal

News

EMA Greenlights Four Drugs for Bladder and Other Cancers

Author:: Drishti Agarwal

Publish date: July 2, 2024

Among the drug approvals the CHMP endorsed was Balversa for the treatment of urothelial carcinoma.

News

Curbing Antibiotic Use Works

Author:: Drishti Agarwal

Publish date: February 26, 2024

A joint effort by European disease control, food safety, and regulatory groups has reduced antibiotic-resistant bacteria, finds report.

News

Mixing Paxlovid With Specific Immunosuppressants Risks Serious Adverse Reactions

Author:: Drishti Agarwal

Publish date: February 14, 2024

The EMA has warned that Paxlovid should only be administered alongside tacrolimus, ciclosporin, everolimus, or sirolimus if their blood levels can ...

News

Hypertriglyceridemia in Young Adults Raises Red Flag

Author:: Drishti Agarwal

Publish date: February 13, 2024

High triglycerides are linked to risk for type 2 diabetes.

News

Higher HDL Tied to Prediabetes Reversion — Up to a Point

Author:: Drishti Agarwal

Publish date: February 8, 2024

After a median follow-up of nearly 3 years, 43% of patients with prediabetes had a reversion to normoglycemia; those with higher HDL-C levels had a...

News

Once-Weekly Insulin Better Than Daily in Type 2 Diabetes

Author:: Drishti Agarwal

Publish date: January 31, 2024

Weekly insulin icodec better at reducing A1c daily basal insulin analogs glargine and degludec over 26-78 months.

News

High levels of concern reported about ED boarding crisis

Author:: Drishti Agarwal

Publish date: November 10, 2023

“There are no low-hanging fruit solutions or simple communication strategies to alleviate these concerns.”